what do glp-1 agonists do Why are being used to treat patients with nonalcoholic fatty liver disease? GLP-1 receptor agonists: Optimising nutritional
Description
Novo Nordisk plans to achieve more than 25 billion DKK ($3.72 billion) in obesity sales by 2025
A Phase III trial of Exenatide in PD (NCT4232969) found that Exenatide was without clinical benefit [56]
Epidemiological data have suggested a correlation between T2D and SA
Tirzepatide induces ferroptosis in glioblastoma cell lines via the SOX2/SLC7A11 axis: a potential therapeutic strategy for glioma treatment
PMID: 3 GisondiPFostiniACFossIGirolomoniGTargherG
When that microbial ecosystem is out of balance, the signal weakens
